ArticleThe American journal of medicine2016
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
Article in The American journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Home Health Aides Caring for Adults With Heart Failure: A Pilot Randomized Clinical Trial.JAMA network open · 2025Trial
- Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.Clinical cardiology · 2018Trial
- Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.European journal of heart failure · 2018Trial
- Cardiac rehabilitation in patients with reduced left ventricular function in Germany: insights from the multicentre MEDIAN Heart Failure Registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Prognostic Value of Early Rehospitalization in Heart Failure Patients.Journal of clinical medicine · 2025Article
- Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure.ESC heart failure · 2024Article
- Leveraging home health aides to improve outcomes in heart failure: A pilot study protocol.Contemporary clinical trials · 2024Article
- Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study.JMIR cardio · 2024Article
- Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post-hospital discharge period.Research involvement and engagement · 2023Review
- Incidence and Risk Factors for 28 Days Hospital Readmission: A Retrospective Study from Oman.Oman medical journal · 2022Article
- Feasibility and effectiveness of a multidimensional post-discharge disease management programme for heart failure patients in clinical practice: the HerzMobil Tirol programme.Clinical research in cardiology : official journal of the German Cardiac Society · 2022Observational
- Readmission following both cardiac and non-cardiac acute dyspnoea is associated with a striking risk of death.ESC heart failure · 2021Article
- Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.The American journal of medicine · 2021Article
- Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers.Clinics (Sao Paulo, Brazil) · 2021Article
- Length of stay and readmission in older adults hospitalized for heart failure.Archives of medical science : AMS · 2021Article
- Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure.Heart failure clinics · 2020Review
- Thirty-Day Hospital Readmissions: A Predictor of Higher All-cause Mortality for Up to Two Years.Cureus · 2020Article
- Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry.Journal of the American Heart Association · 2020Observational
- Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.Heart and vessels · 2019Article
- Neural networks versus Logistic regression for 30 days all-cause readmission prediction.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundHeart failure is the leading cause for 30-day all-cause readmission. We examined the impact of 30-day all-cause readmission on long-term outcomes and cost in a propensity score-matched study of hospitalized patients with heart failure.
methodsOf the 7578 Medicare beneficiaries discharged with a primary diagnosis of heart failure from 106 Alabama hospitals (1998-2001) and alive at 30 days after discharge, 1519 had a 30-day all-cause readmission. Using propensity scores for 30-day all-cause readmission, we assembled a matched cohort of 1516 pairs of patients with and without a 30-day all-cause readmission, balanced on 34 baseline characteristics (mean age 75 years, 56% women, 24% African American).
resultsDuring 2-12 months of follow-up after discharge from index hospitalization, all-cause mortality occurred in 41% and 27% of matched patients with and without a 30-day all-cause readmission, respectively (hazard ratio 1.68; 95% confidence interval 1.48-1.90; P <.001). This harmful association of 30-day all-cause readmission with mortality persisted during an average follow-up of 3.1 (maximum, 8.7) years (hazard ratio 1.33; 95% confidence interval 1.22-1.45; P <.001). Patients with a 30-day all-cause readmission had higher cumulative all-cause readmission (mean, 6.9 vs 5.1; P <.001), a longer cumulative length of stay (mean, 51 vs 43 days; P <.001), and a higher cumulative cost (mean, $38,972 vs $34,025; P = .001) during 8.7 years of follow-up.
conclusionsAmong Medicare beneficiaries hospitalized for heart failure, 30-day all-cause readmission was associated with a higher risk of subsequent all-cause mortality, higher number of cumulative all-cause readmission, longer cumulative length of stay, and higher cumulative cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.